24
11
1
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TMAZ-0071A |
Anti-APOE Monoclonal Antibody-APC
|
||
TMAZ-0071P |
Anti-APOE Monoclonal Antibody-PE
|
||
TMAZ-0071B |
Anti-APOE Monoclonal Antibody-Biotin
|
||
TMAZ-0071A6 |
Anti-APOE Monoclonal Antibody-AF647
|
||
TMAZ-0071A5 |
Anti-APOE Monoclonal Antibody-AF555
|
||
TMAZ-0071A4 |
Anti-APOE Monoclonal Antibody-AF488
|
||
TF0003 |
Anapoe-NID-P40
|
Others | Others |
Anapoe-NID-P40 是一种有用的有机化合物,可用于生命科学领域的相关研究。其产品编号为 TF0003,CAS号为 2497-59-8。 | |||
TF0002 |
Anapoe-C12E10
|
Others | Others |
Anapoe-C12E10 是一种有用的有机化合物,可用于生命科学领域的相关研究。其产品编号为 TF0002,CAS号为 6540-99-4。 | |||
TF0093 |
Anapoe-EH-9
|
Others | Others |
Anapoe-EH-9 是一种有用的有机化合物,可用于生命科学领域的相关研究。其产品编号为 TF0093,CAS号为 64366-70-7。 | |||
TF0094 |
Anapoe-C13E8
|
Others | Others |
Anapoe-C13E8 是一种有用的有机化合物,可用于生命科学领域的相关研究。其产品编号为 TF0094,CAS号为 9043-30-5。 | |||
TF0095 |
Anapoe-X-114
|
Others | Others |
Anapoe-X-114 是一种有用的有机化合物,可用于生命科学领域的相关研究。其产品编号为 TF0095,CAS号为 9036-19-5。 | |||
TF0092 |
Anapoe-58
|
Others | Others |
Anapoe-58 是一种有用的有机化合物,可用于生命科学领域的相关研究。其产品编号为 TF0092,CAS号为 9004-95-9。 | |||
TF0051 |
Anapoe-C10E9
|
Others | Others |
Anapoe-C10E9 是一种有用的有机化合物,可用于生命科学领域的相关研究。其产品编号为 TF0051,CAS号为 26183-52-81。 | |||
T5128 |
RGX-104 hydrochloride
SB742881,RGX-104 HCl,盐酸RGX-104 |
Liver X Receptor | Metabolism |
RGX-104 hydrochloride (SB742881) 是小分子LXR 激动剂,利用 ApoE 基因的转录激活,调节先天免疫。 | |||
T7768 |
RGX-104
RGX-104 free Acid |
Liver X Receptor | Metabolism |
RGX-104 (RGX-104 free Acid) 是一种口服具有活力的肝X 核激素受体激动剂,通过 ApoE 基因的转录激活调节先天免疫。 | |||
T15265 |
EZ-482
|
Others | Others |
EZ-482 is a novel ligand of apolipoprotein (apoE). EZ-482 binds to apoE4 by a unique N-terminal allosteric effect and it also binds to sites on apoE in the C-terminal domain (Kds: 5-10 μM for apoE3 and apoE4). | |||
T30998 |
COG1410
COG-1410,COG 1410 |
||
COG-1410 is an apolipoprotein E (apoE) peptide mimetic. | |||
T68696 |
AZ-2
|
Others | Others |
AZ-2 is an inducer of ABCA1 and apoE. It enhances ABCA1 activity and decreases P2X7 receptor activity. AZ-2 activates endogenous LXR signaling but shows no direct LXRα or LXRβ agonist activity. | |||
T75778 |
COG 133 TFA
|
Others | Others |
COG 133 TFA 是载脂蛋白 E (Apolipoprotein E, APOE) 肽的片段。COG 133 与 ApoE 全息蛋白竞争结合 LDL 受体,具有有效的抗炎和神经保护作用。COG 133 TFA 也是nAChR 拮抗剂,IC50为 445 nM。 | |||
T85217 |
Cholesteryl Palmitoleate
Cholesterol Palmitoleate,16:1(9Z) Cholesterol ester,CE(16:1),16:1(9Z) CE |
Others | Others |
Cholesteryl palmitoleate, a cholesterol ester, exhibits elevated plasma levels in ApoE-/- mice following exposure to cigarette smoke and in pediatric patients diagnosed with biliary atresia. It serves as a standard for identifying cholesterol esters in human meibomian gland secretions. | |||
T68668 |
AZ-1
|
Others | Others |
AZ-1 is an inducer of ABCA1 and apoE. It enhances ABCA1 activity and decreases P2X7 receptor activity. AZ-1 activates endogenous LXR signaling but shows no direct LXRα or LXRβ agonist activity. | |||
T83710 |
Gastric Inhibitory Peptide (22-51) (human) TFA
GIP (22-51),Glucose-dependent Insulinotropic Peptide (22-51) |
||
胃抑制肽(GIP) (22-51) 是一种具有30个氨基酸的前动脉硬化肽,对应于GIP前体蛋白proGIP的第22至51个氨基酸残基,已在人类血浆中发现。在1 µM的浓度下使用,该肽能引起在巨峰细胞分化的THP-1细胞和分离的人类主动脉内皮细胞中IκB-α的降解和NF-κB的核转移。在体内,GIP (22-51) 增加了ApoE-/-小鼠的动脉粥样硬化病变面积和斑块形成。 | |||
T83669 |
PMX-53 TFA
AcPhe-[Orn-Pro-D-Cyclohexylalanine-Trp-Arg],AcF-[OPdChaWR],3D53 |
||
PMX-53是一种大环型补体5a (C5a) 类肽模拟物及C5a受体的拮抗剂(IC50 = 0.3 µM)。它能抑制C5a诱导的人类分离性多形核白细胞(PMNs)中的髓过氧化物酶(MPO)分泌。在大鼠腹膜亚瑟斯反应模型中,PMX-53(10 mg/kg, p.o.)能够抑制血管渗漏、多形核白细胞浸润以及腹膜TNF-α和IL-6的产生。在3-硝基丙酸(3-NP)诱导的亨廷顿病大鼠模型中,它能减少体重损失和厌食,抑制纹状体退化。PMX-53(3 mg/kg)还能在ApoE-/-小鼠中减小动脉粥样硬化斑块大小和脂质含量。 | |||
T85301 |
ABO hydrochloride
|
Others | Others |
ABO acts as an annexin A7 modulator, specifically binding to Thr286 to inhibit its phosphorylation on threonine (not on serine or tyrosine) residues within human umbilical vein endothelial cells (HUVECs). This compound furthers the annexin A7 interaction with the EF-hand protein GCA, leading to reduced GCA phosphorylation, lowered intracellular calcium levels, and enhanced autophagy in COS-7 cells. Moreover, ABO lessens phosphorylation of the microtubule-associated protein 1 light chain (LC3) in... |
Cat. No. | Product Name | Species | Expression System |
---|---|---|---|
TMPH-02421 |
APOE Protein, Cynomolgus, Recombinant (His & Myc)
Apolipoprotein E,Apo-E,APOE |
Cynomolgus | E. coli |
APOE Protein, Cynomolgus, Recombinant (His & Myc) is expressed in E. coli expression system with N-10xHis and C-Myc tag. The predicted molecular weight is 39.0 kDa and the accession number is P10517. | |||
TMPJ-00805 |
Apolipoprotein E/APOE Protein, Mouse, Recombinant (His)
Apo-E,APOE,Apolipoprotein E |
Mouse | HEK293 Cells |
Apolipoprotein E (Apo-E), is a member of the apolipoprotein A1/A4/E family. ApoE is a major protein component of serum LDL, VLDL, HDL, and chylomicrons. APOE may function in mediating the binding, internalization, and catabolism of lipoprotein particles. It can serve as a ligand for the LDL (apo B/E) receptor and for the specific apo-E receptor (chylomicron remnant) of hepatic tissues. APOE is usually secreted in plasma. Phosphorylation sites are present in the extracellular medium. | |||
TMPH-03199 |
APOE Protein, Rabbit, Recombinant (His & Myc & SUMO)
APOE,Apolipoprotein E,Apo-E |
Rabbit | E. coli |
APOE Protein, Rabbit, Recombinant (His & Myc & SUMO) is expressed in E. coli expression system with N-10xHis-SUMO and C-Myc tag. The predicted molecular weight is 53.6 kDa and the accession number is P18287. | |||
TMPK-00788 |
Apolipoprotein E/APOE Protein, Mouse, Recombinant (hFc)
apolipo E,Apo-E,Apolipoprotein E,APOE |
Mouse | HEK293 Cells |
Apolipoprotein E (apoE) is a lipid carrier in both the peripheral and the central nervous systems. Lipid-loaded apoE lipoprotein particles bind to several cell surface receptors to support membrane homeostasis and injury repair in the brain. Considering prevalence and relative risk magnitude, the ε4 allele of the APOE gene is the strongest genetic risk factor for late-onset Alzheimer's disease (AD). Apolipoprotein E/APOE Protein, Mouse, Recombinant (hFc) is expressed in HEK293 mammalian cells wi... | |||
TMPK-00762 |
Apolipoprotein E/APOE3 Protein, Human, Recombinant (hFc)
APOE,Apo-E,Apolipoprotein E,APOE3,apolipo ... |
Human | HEK293 Cells |
Apolipoprotein E (apoE) is a lipid carrier in both the peripheral and the central nervous systems. Lipid-loaded apoE lipoprotein particles bind to several cell surface receptors to support membrane homeostasis and injury repair in the brain. Considering prevalence and relative risk magnitude, the ε4 allele of the APOE gene is the strongest genetic risk factor for late-onset Alzheimer's disease (AD). Apolipoprotein E/APOE3 Protein, Human, Recombinant (hFc) is expressed in HEK293 mammalian cells w... | |||
TMPJ-00756 |
Apolipoprotein E/APOE3 Protein, Human, Recombinant (His)
Apolipoprotein E,Apo-E,APOE,ApoE3 |
Human | HEK293 Cells |
ApoE, a glycoprotein, is a structural component of very low density lipoprotein (vLDL) synthesized by the liver and intestinally synthesized chylomicrons . ApoE is also a constituent of a subclass of high density of lipoproteins (HDL) involved in cholesterol transport .ApoE mediates high affinity binding of chylomicrons and vLDL particles to the LDL receptor, allowing for specific uptake of these particles by the liver, preventing the accumulation of cholesterol rich particles in the plasma .Apo... | |||
TMPK-00588 |
Apolipoprotein E/APOE4 Protein, Human, Recombinant (hFc)
Apolipoprotein E,Apo-E,apolipo E,APOE4,APOE |
Human | HEK293 Cells |
Apolipoprotein E (apoE) is a lipid carrier in both the peripheral and the central nervous systems. Lipid-loaded apoE lipoprotein particles bind to several cell surface receptors to support membrane homeostasis and injury repair in the brain. Considering prevalence and relative risk magnitude, the ε4 allele of the APOE gene is the strongest genetic risk factor for late-onset Alzheimer's disease (AD). Apolipoprotein E/APOE4 Protein, Human, Recombinant (hFc) is expressed in HEK293 mammalian cells w... | |||
TMPK-00589 |
Apolipoprotein E/APOE4 Protein, Human, Recombinant (His)
APOE,apolipo E,Apo-E,APOE4,Apolipoprotein ... |
Human | HEK293 Cells |
Apolipoprotein E (apoE) is a lipid carrier in both the peripheral and the central nervous systems. Lipid-loaded apoE lipoprotein particles bind to several cell surface receptors to support membrane homeostasis and injury repair in the brain. Considering prevalence and relative risk magnitude, the ε4 allele of the APOE gene is the strongest genetic risk factor for late-onset Alzheimer's disease (AD). Apolipoprotein E/APOE4 Protein, Human, Recombinant (His) is expressed in HEK293 mammalian cells w... | |||
TMPK-00763 |
Apolipoprotein E/APOE3 Protein (Primary Amine Labeling), Human, Recombinant (His), Biotinylated
APOE3,Apo-E,apolipo E,Apolipoprotein E,APOE |
Human | HEK293 Cells |
Apolipoprotein E (apoE) is a lipid carrier in both the peripheral and the central nervous systems. Lipid-loaded apoE lipoprotein particles bind to several cell surface receptors to support membrane homeostasis and injury repair in the brain. Considering prevalence and relative risk magnitude, the ε4 allele of the APOE gene is the strongest genetic risk factor for late-onset Alzheimer's disease (AD). Apolipoprotein E/APOE3 Protein (Primary Amine Labeling), Human, Recombinant (His), Biotinylated i... | |||
TMPY-05297 |
Apolipoprotein E/APOE3 Protein, Human, Recombinant (His & Trx)
LPG,apolipoprotein E,ApoE4,APO-E,LDLCQ5,AD2 |
Human | E. coli |
Apolipoprotein E/APOE3 Protein, Human, Recombinant (His & Trx) is expressed in E. coli expression system with His and Trx tag. The predicted molecular weight is 51.3 kDa and the accession number is P02649. | |||
TMPY-05528 |
Apolipoprotein E/APOE3 Protein, Human, Recombinant (His & Trx), Biotinylated
APO-E,LDLCQ5,LPG,ApoE4,AD2,apolipoprotein E |
Human | E. coli |
Apolipoprotein E/APOE3 Protein, Human, Recombinant (His & Trx), Biotinylated is expressed in E. coli expression system with His and Trx tag. The predicted molecular weight is 51.3 kDa and the accession number is P02649. |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T71306 |
Gemfibrozil-d6
|
||
Gemfibrozil-d6 is intended for use as an internal standard for the quantification of gemfibrozil by GC- or LC-MS. Gemfibrozil is a peroxisome proliferator-activated reporter α and PPARγ agonist. In vivo, gemfibrozil reduces serum total cholesterol, triglyceride, and LDL levels in a rat model of high-cholesterol diet-induced hyperlipidemia. Gemfibrozil reduces atherosclerotic plaque area, superoxide production, and expression of the genes encoding the NF-κB subunit p65 and chemokine (C-C) motif l... |